Article Text

Download PDFPDF
Correspondence
The Authors' reply
  1. Jolanta M Siller-Matula1,
  2. Bernd Jilma2
  1. 1Department of Cardiology, Medical University of Vienna, Vienna, Austria
  2. 2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
  1. Correspondence to Bernd Jilma, Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria; bernd.jilma{at}meduniwien.ac.at

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Authors' reply We thank Dr Lin and colleagues for their interest1 regarding our recent article.2 The usefulness of a 600 mg clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention (PCI) was not investigated in randomised clinical trials. As correctly stated by the authors, the study would require a very large sample size, which is driven by a low …

View Full Text

Footnotes

  • Linked articles 300251.

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles